CurrentRheuma — Osteoporosis & bone health

Association between cognitive trajectories and subsequent hip fracture risk: a multinational prospective cohort study

2026-11-13T23:15:27.309Z

Cohort study · Osteoporos Int, 2026.

Physical and psychosocial morbidity in pregnancy and lactation-associated osteoporosis: a comprehensive mixed-methods study

2026-11-13T23:15:27.309Z

Case-control study · Osteoporos Int, 2026.

Sedative-hypnotic use and its association with osteoporosis and fractures: a national analysis, 1999–2020

2026-11-07T00:15:31.319Z

Cross-sectional study · Osteoporos Int, 2026.

Agreement between radiofrequency echographic multispectrometry and dual-energy X-ray absorptiometry for assessing bone mineral density in older patients during the acute phase following hip fracture

2026-11-05T13:24:18.717Z

Cohort study · Osteoporos Int, 2026.

Clinical role and timing of osteoporosis evaluation and treatment after distal radius fracture: a scoping review

2026-11-05T13:24:18.717Z

Research article · Osteoporos Int, 2026.

Comorbidities and outcomes associated with young adult hip fracture: a systematic review and meta-analysis

2026-11-05T13:24:18.717Z

Meta-analysis · Osteoporos Int, 2026.

Denosumab biosimilar HLX14 versus EU-denosumab in postmenopausal women at high fracture risk: a randomized, double-blind, multicenter phase 3 trial

2026-11-05T13:24:18.717Z

Randomized controlled trial · Osteoporos Int, 2026.

Hospitalisation and subsequent fracture risk—a national matched cohort study in Denmark

2026-11-05T13:24:18.717Z

Cohort study · Osteoporos Int, 2026.

Intrinsic capacity is associated with fracture risk in older women with osteoporosis

2026-11-05T13:24:18.717Z

Research article · Osteoporos Int, 2026.

Preventing re-fractures in Western Sydney: three-year outcomes of an Australian fracture liaison service utilising a novel automated fracture-finding Tool

2026-11-05T13:24:18.717Z

Research article · Osteoporos Int, 2026.

The role of the CYP1A1 gene in long-term glucocorticoid-related adverse effects

2026-11-05T13:24:18.717Z

Research article · Osteoporos Int, 2026.

Association between the frequency of achieving recommended daily step counts and a decline in quantitative ultrasound measurements in premenopausal and postmenopausal women: a 4-year prospective study of the Tohoku Medical Megabank Community-Based Cohort study

2026-11-05T13:10:58.883Z

Cohort study · Osteoporos Int, 2026.

Fractures and mortality prediction by opportunistic screening of osteoporosis

2026-11-05T13:10:58.883Z

Diagnostic or prognostic study · Osteoporos Int, 2026.

Hip fracture risk in patients with Cushing’s syndrome: a population-based cohort study

2026-11-05T13:10:58.883Z

Cohort study · Osteoporos Int, 2026.

Prevalence of osteoporosis and osteopenia in patients with rotator cuff tears: a systematic review and meta-analysis

2026-11-05T13:10:58.883Z

Meta-analysis · Osteoporos Int, 2026.

Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians

2026-11-04T23:59:25.899Z

Meta-analysis · Ann Intern Med, 2023. Fractures: Bisphosphonates and denosumab reduced hip, clinical and radiographic vertebral, and other clinical fractures in postmenopausal females with osteoporosis (moderate to high certainty of evidence (CoE))

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians

2026-11-04T23:59:25.899Z

Guideline or statement · Ann Intern Med, 2023.

Comparison of Fractures Among Older Adults Who Are Ambulatory vs Those Who Use Wheelchairs in Sweden

2026-11-04T23:58:57.553Z

Cohort study · JAMA Netw Open, 2023. Fracture — Wheelchair vs Ambulatory controls: HR (any fracture) 0.43 (95% CI 0.41-0.44)

A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Hospitalisation for VFF: Over 75 years 64,370 (65%); bed days 1.5 million; cost £465 million; Median length of stay (MLOS) 14.4 days · 55-74 years: bed days 659,000; cost £239 million; MLOS 10.7 days

A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Low ALP (< 30 IU/L), prevalence: Osteoporosis clinic 168 (9%); low ALP for ≥ 2 months 50 (2.7%); persistently low ALP seven (0.4%) · Hospital-wide 0.6% · AFF 2 (2/22)

A nomogram for predicting residual low back pain after percutaneous kyphoplasty in osteoporotic vertebral compression fractures

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Independent risk factors for residual low back pain: Independent risk factors: Preoperative bone mineral density (pre-BMD), smoking history, thoracolumbar fascia injury (TLFI), facet joint injury (FJI) and incomplete cementing of the fracture line (ICFL) P < 0.05

A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

2026-11-04T23:54:17.389Z

Guideline or statement · Osteoporos Int, 2023.

Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. 10 years: The probability ratio rose progressively as the number of reported falls increased

Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Risk factors for multiple fractures: Risk factors for multiple fractures at any site: age, history of fracture, history of fall, total hip bone mineral density (BMD), spine BMD and RA

Association of covert brain infarcts and white matter hyperintensities with risk of hip fracture in older adults: the Cardiovascular Health Study

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Incident hip fracture, demographic-adjusted, mean follow-up of 12.8 years — ≥ 1 covert infarct vs No infarcts: HR 1.32 (95% CI 1.08-1.62); 32% higher hazard

Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Baseline PINP and ≥ 3% increased BMD in both TH and FN (multiple regression), 12 months: Only baseline PINP was significantly and independently associated with ≥ 3% increased BMD in both TH and FN; 95% CI 1.006-1.054

Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study

2026-11-04T23:54:17.389Z

Cross-sectional study · Osteoporos Int, 2023. Bone, cognitive and anthropometric characteristics across fracture sites: The four fracture site groups differed significantly in education level, bone mineral density (BMD), body mass index (BMI), fear of falling and number of errors in the Trail Making Test B (executive function)

Bone density and trabecular bone score to predict fractures in adults aged 20–39 years: a registry-based study

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Incident MOF / any fracture — Osteopenia: aHR (MOF/any fracture) 1.20/1.45

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. LS BMD mean change (g/cm2), 1 year: NT mean - 0.041 (95% CI - 0.062 to - 0.021) g/cm2 · RIS mean - 0.035 (95% CI - 0.052 to - 0.017) g/cm2 · ALN mean - 0.005 (95% CI - 0.020 to 0.009) g/cm2 · ZOL mean - 0.009 (95% CI - 0.025 to 0.008) g/cm2

Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study

2026-11-04T23:54:17.389Z

Cross-sectional study · Osteoporos Int, 2022. Association of lipid profiles with BMD (adjusted for age and BMI): Triglycerides negatively associated with whole-body BMD in both men and women p < 0.05

C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Association of higher hsCRP with bone loss, microarchitecture and fracture: Higher hsCRP associated with faster increase in aBMD at whole body and lumbar spine, but not other sites

Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

2026-11-04T23:54:17.389Z

Secondary analysis · Osteoporos Int, 2022. Bone turnover markers before ZOL — 9 M vs 6 M; p < 0.001; higher CTX and PINP in the 9 M and 12 M groups vs 6 M

Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury

2026-11-04T23:54:17.389Z

Diagnostic or prognostic study · Osteoporos Int, 2022. Discrimination of prevalent fracture history (AUC): CT-based indices outperformed DXA-based indices at all sites

The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review

2026-11-04T23:54:17.389Z

Research article · Osteoporos Int, 2023. All osteoporotic fractures (4 RCTs): No statistically significant reduction in osteoporotic fracture risk vs usual care

Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial

2026-11-04T23:54:17.389Z

Secondary analysis · Osteoporos Int, 2023. HRQoL, osteoporosis knowledge and health beliefs, 12 and 18 months: No significant effects of the Osteo-cise program on HRQoL, osteoporosis knowledge or health beliefs relative to controls

Epidemiology of male osteoporosis in Denmark (1996–2018)

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. 1996-2018: Overall age-standardized incidence rate, per 1000 person-years (95% CI 8.5-8.6); varying between 7.7 and 9.7 8.6

Ethnic disparities in fracture risk assessment using polygenic scores

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Fracture per SD decrease in best-performing PGS: European: HR 1.24 (1.22-1.27) · African: HR 1.28 (0.83-1.99) · Asian: HR 1.34 (1.10-1.64)

Exercise and the prevention of major osteoporotic fractures in adults: a systematic review and meta-analysis with special emphasis on intensity progression and study duration

2026-11-04T23:54:17.389Z

Meta-analysis · Osteoporos Int, 2022. Major osteoporotic fractures — EG vs CG: RR 0.75 (95% CI 0.54-0.94); p = .006

Exome-wide screening identifies novel rare risk variants for bone mineral density

2026-11-04T23:54:17.389Z

Research article · Osteoporos Int, 2023. Gene-based burden test of exonic variants, BMD analysis: ANKRD18A P = 1.60 × 10-5, PBonferroni adjust = 2.11 × 10-3

Follicle-stimulating hormone is associated with low bone mass in postmenopausal women

2026-11-04T23:54:17.389Z

Cross-sectional study · Osteoporos Int, 2023. Low bone mass/osteoporosis at the femoral neck — Highest FSH tertile vs Lowest FSH tertile: OR 2.98 (95% CI 1.86-4.77); fully adjusted logistic regression

Fracture liaison service model: project design and accreditation

2026-11-04T23:54:17.389Z

Research article · Osteoporos Int, 2022. Drafted FLS model: Reference operational model describing identification, diagnostic framing and initiation of appropriate secondary prevention programmes for individuals with a recent fragility fracture of the femur

Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Major fracture rate: Year prior to ICI 11.3 per 1000 patient-years · Year 1 after ICI 27.3 per 1000 patient-years · Year 2 after ICI 17.6 per 1000 patient-years

Fracture risk in Parkinson’s disease according to its severity and duration

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Any fracture — PD vs Comparison: aHR 1.49 (95% CI 1.44-1.56)

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Pelvic fractures, full cohorts — GR risedronate vs IR risedronate: aIRR 0.37; p < 0.05

Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Incidence of subsequent fracture by frailty deficit group: 1 deficit item 25.0 (95% CI 22.4 to 27.8) per 1000 older adults · 4 to 12 deficit items 31.8 (95% CI 28.0 to 35.8) per 1000

Frailty, length of stay and cost in hip fracture patients

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Total hospitalization costs, median: High HFRS median 22,432 SGD$ · Intermediate HFRS median 18,759 SGD$ · Low HFRS median 15,671 SGD$

The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture – a development and validation study from the Registry for Geriatric Trauma (ATR-DGU)

2026-11-04T23:54:17.389Z

Diagnostic or prognostic study · Osteoporos Int, 2023. AUC of the final model 0.727 (95% CI 0.711 - 0.742)

The high-risk hip fracture patient and the palliative care consult : A retrospective study to investigate risks of complications and the utility of a palliative care consult in hip fracture patients undergoing surgical fixation

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2022. Independent risk factors for post-surgical complications: Decreased pre-injury ambulatory status: OR (95% CI), p 2.18 (1.13-4.20), p = .02

Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study

2026-11-04T23:54:17.389Z

Cohort study · Osteoporos Int, 2023. Kidney, bone and cardiovascular outcomes by UCaE: UCaE correlated positively with eGFR but did not affect the rate of eGFR decline over time

Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review

2026-11-04T23:54:17.389Z

Meta-analysis · Osteoporos Int, 2023. Implementations at the hospital level 90%